Micromidas, Inc.
USPTO PatentsView assignee record - 24 granted patents across 7 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Micromidas ranks #12,561 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 7 technology areas.
- #12,561
- of 49,997 US assignees by volume
- Top 49%
- by Innovation Score (35.5/100)
- 25.0
- avg claims per patent
- -86%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12561 · US Corporation #12,561 · 24 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 24 grants
- MID-PACK #12,561/49,997
- PHOTO-FINISH Mdsave Shared Services
- CPC-NARROW C07D · 7 areas
- INNOV-THIN 35.5/100
- CLAIMS-DENSE 25.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -86% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mdsave Shared Services Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Micromidas’s 35.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Micromidas
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Micromidas · this assignee
Micromidas · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Micromidas's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Micromidas?
Each dot is one of Micromidas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Micromidas’s own 25.0 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Micromidas's grants concentrate
Micromidas, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 75% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2015. By volume, Micromidas sits between Mdsave Shared Services Inc. and Mobility Holdings, Limited.
Who files at Micromidas's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mdsave Shared Ser…
Mdsave Shared Services Inc.
24 patents
- Medicon Pharmaceu…
Medicon Pharmaceuticals, Inc.
24 patents
- Merge Healthcare…
Merge Healthcare Solutions Inc.
24 patents
- Mi-jack Products
Mi-jack Products, Inc.
24 patents
- Mitac Internation…
Mitac International Corp.
24 patents
- Mitsubishi Heavy…
Mitsubishi Heavy Industries Machinery Technology Corporation
24 patents
- Moba Mobile Autom…
Moba Mobile Automation AG
24 patents
- Mobility Holdings
Mobility Holdings, Limited
24 patents
- Micromidas ◀
Micromidas, Inc.
24 patents
What this shows Micromidas holds 24 patents at rank #12,546, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Micromidas
By rank, the assignees closest to #12,546 in granted patent volume.
- Mdsave Shared Services Inc. #12,542 · 24 patents
- Medicon Pharmaceuticals, Inc. #12,543 · 24 patents
- Merge Healthcare Solutions Inc. #12,544 · 24 patents
- Mi-jack Products, Inc. #12,545 · 24 patents
- Mitac International Corp. #12,547 · 24 patents
- Mitsubishi Heavy Industries Machinery Technology Corporation #12,548 · 24 patents
- Moba Mobile Automation AG #12,549 · 24 patents
- Mobility Holdings, Limited #12,550 · 24 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Micromidas's primary technology class.
Micromidas's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 4.2% |
| 2016 | 3 | 12.5% |
| 2017 | 6 | 25.0% |
| 2018 | 6 | 25.0% |
| 2019 | 5 | 20.8% |
| 2020 | 3 | 12.5% |
Which technologies does Micromidas, Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Micromidas, Inc.'s patent record in context - here's where to go next.
- Micromidas, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 75% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #12,561 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Micromidas, Inc. against Mdsave Shared Services Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.